Insights - Yesterday Essa (EPIX) announced it dosed the first patient in their Phase 1 mCRPC study. EPIX is up 30% since we first covered it back in late … Continue Reading
PremiumInsights - AC Immune (ACIU) is up 60% in pre-market after the company announced it was advancing their anti-tau vaccine in Alzheimer’s Disease (AD) to higher dosing cohorts. Although … Continue Reading
Read nowInsights - Magenta (MGTA) is pursuing two of the largest challenges in stem cell transplants; mobilizing stem cells and conditioning patients for transplants. Overcoming these challenges will … Continue Reading
PremiumInsights - Bellus announced Phase 2 data this morning and it was a major flop. The stock is down 75%. Bellus did not hit statistical significance in any of … Continue Reading
PremiumInsights - Fennec is up 50% since announcing their financing on April 30, 2020 @ 6.25/share. During this time, volume has picked up significantly, with 8.5M total … Continue Reading
PremiumInsights - Affimed (AFMD) has been on a tear lately as markets are starting to realize the potential of the company’s pipeline. It is trading above $4/share … Continue Reading
PremiumInsights - We had a call with Essa (EPIX) management earlier today. The initial thesis was that Essa’s second-generation drug would address the issues and potency limitations … Continue Reading
Premium
